Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:52 PM
Ignite Modification Date:
2025-12-24 @ 7:52 PM
NCT ID:
NCT04742504
Eligibility Criteria:
Inclusion Criteria:
* .It is mandatory that all patients can comprehend the study requirements and provide informed consent for their participation in MEGA.
Group A:
* Adult people (≥ 18 and ≤ 80 years old) with eosinophilic severe asthma requiring high-dose inhaled corticosteroids plus long-acting beta agonists (with or without long-acting muscarinic antagonist or Montelukast or oral corticosteroids)
* Benralizumab treatment approved.
Group B:
.Patients with allergic asthma (prick test or RAST positive).
Exclusion Criteria:
* Patients with continuous OCS treatment
* Patients with Immunosuppressive drugs
* Patients with primary or secondary immune deficiency,
* Patients with chronic or/and concomitant disease, presence of severe systemic disease or cancer,
* Patients with possible infestation by parasites.
* Patients with other acute or chronic active lung disorders Patients with significant psychiatric disorders
* Patients with biological treatment will be excludes for group B
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT04742504
Study Brief:
Protocol Section:
NCT04742504